Immunochemical and enzymatic study of ceruloplasmin in rheumatoid arthritis.
Forty adult patients (30 women and 10 men) with rheumatoid arthritis (RA), treated with nonsteroidal anti-inflammatory drugs, were studied. Serum levels of immunoreactive ceruloplasmin, oxidase activity of the ceruloplasmin and total copper, as well as the specific oxidase activity (enzyme activity per unit of mass) and the copper/immunoreactive ceruloplasmin relationship were significantly higher in the group of patients than in the healthy control group (p < 0.001). However, no significant difference was found for the concentration of non-ceruloplasmin copper between both groups. A statistically significant negative correlation was obtained for the concentration of serum thiobarbituric acid-reacting substances with the immunoreactive ceruloplasmin and its oxidase activity in the group of patients (p < 0.005). These results suggest that in RA increases of serum copper are produced at the expense of the fraction linked to the ceruloplasmin, diminishing the proportion of apoceruloplasmin and other forms poor in copper. Although the increase in the serum concentration of ceruloplasmin might offer an additional safeguard against oxidative stress. it does not appear to have a beneficial effect upon the activity of the illness as evaluated by means the biological inflammation markers C-reactive protein, erythrocyte sedimentation rate and sialic acid.
Louro
M O
MO
Laboratorio Central, Hospital General de Galicia, Clinico Universitario, Santiago de Compostela, Spain.
Cocho
J A
JA
Mera
A
A
Tutor
J C
JC
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000201:enzymology*; D002570:Ceruloplasmin / Q000378:metabolism*; D003300:Copper / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013379:Substrate Specificity; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism
D017392:Thiobarbituric Acid Reactive Substances; D003300:Copper; D002570:Ceruloplasmin